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The novel coronavirus severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic,
and concerns about possible maternal, foetal and neonatal
adverse outcomes have been raised. Recently, possible vertical
transmission of SARS-CoV-2 has been suspected in four cases
with positive placental swabs and in two cases with elevated
IgM in the neonate [1e4]. The primary aim of this letter is to
report the rate of vertical transmission in a series of women
infected during the third trimester of pregnancy.
We performed a retrospective case series of all women with
SARS-CoV-2 infection during pregnancy admitted to the Univer-
sity Hospital of Lausanne for delivery between 1 April and 6 May
2020. We included all pregnant women who delivered after
24 weeks of gestation with a positive RT-PCR nasopharyngeal
swab or positive serology (IgG) for SARS-CoV-2 after contact with
individuals who tested positive for SARS-CoV-2 via RT-PCR.
Within minutes of placental expulsion, the fetal surface of the
placenta was disinfected (octenidine dihydrochloride) and
incised with a sterile scalpel; two swabs (close to the umbilical
cord and peripheral margin) were obtained and tested for SARS-
CoV-2 by RT-PCR. This study was approved by the local ethics
committee (no2020-00548).* Corresponding author: D. Baud.
E-mail address: david.baud@chuv.ch (D. Baud).
https://doi.org/10.1016/j.cmi.2020.06.035
1198-743X/© 2020 European Society of Clinical Microbiology and Infectious Diseases. PThirteen women with SARS-CoV-2 infection during pregnancy
were identified (12 with positive nasopharyngeal PCR and one who
was symptomatic with positive serology but three negative PCRs).
Baseline characteristics, medical history, course of the disease,
maternal and neonatal outcomes, and results of the placental, cord
blood and nasopharyngeal neonatal PCR swabs are summarized in
Table 1.
None of the placenta, cord blood nor neonate nasopharyngeal
swabs were positive for SARS-CoV-2. This is concordant with the
other published case series, although Alzamora et al. reported one
case of a positive SARS-CoV-2 PCR swab in a neonate born by
caesarean section from a severely ill mother [5]. Hu et al. also re-
ported one neonate positive for SARS-CoV-2, born by caesarean
section from a woman with mild symptoms with a negative am-
niotic fluid SARS-CoV-2 PCR [6]. Two other case reports raise con-
cerns about vertical transmission based on the presence of IgM and
IgG antibodies in two neonates born from mothers with corona-
virus disease 2019 (COVID-19) [1,2]. Penfield et al. suspected that
the mode of delivery may also potentially increase the risk of ver-
tical transmission [3]. Indeed, the placenta/neonate could be
contaminated at delivery by maternal infected faeces. Maternal
faecal samples were not tested in our series, although symptomatic
individuals, especially those with digestive symptoms, excrete the
virus in their stool. In our series, however, the absence of vertical
transmission is observed even in the context of a high rate of
vaginal births (11 out of 13).
These results and the high proportion of negative results
among newborn infants from infected mothers could indicate
that maternaleplacentalefoetal infection seems to be a rare
event and that vertical transmission remains difficult to prove
because of the possible clearance of viral RNA in both the
placenta and the foetus, or the need for a longer incubation time
to be detected after birth.
Out of 13 women, one had a critical course of COVID-19. She
required 8 days of mechanical ventilation. The course of the
disease was otherwise favourable in our series with no maternal
deaths and only one critical case with acute respiratory distressublished by Elsevier Ltd. All rights reserved.
Table 1
Personal and medical history, pregnancy and neonatal outcomes, results of SARS-CoV-2 PCR swabs











Neonatal outcome SARS-CoV-2 PCR
Weight (g) % Apgar score pH Days at
discharge
Breastfeeding Placenta Cord blood Neonate
nasopharynx





Vaginal 3280 30 9-10-10 7.21e7.37 2 Yes Neg Neg Neg
2 1 0 Average 18 Obesity BMI 38 kg/m2 None Mild/Cough,
dysphonia
Vaginal 3950 75 9-10-10 7.20e7.36 5 No Neg Neg d







occlusive crisis times of
which one was due to
COVID-19
Mild/Cough Vaginal 2820 25 Not done 7.16e7.27 8 No Neg d Neg
4 1 0 d 39 None None Critical/Fever,
cough, ARDS,
headaches
CS 1800 40 6-6-7 7.28 45 (NICU for
prematurity)
No Neg Neg Neg





Vaginal 3880 75 3-9-10 7.14e7.22 2 Yes Neg Neg Neg
6 1 0 High 31 None None Mild/Dysgueusia,
anosmia
Forceps 3100 15 9-9-10 7.21e7.26 3 Yes Neg Neg
7 1 0 High 31 None None Mild Vaginal 2950 10 2-7-7 6.96-7.09 13 (NICU for
neonatal
asphyxia)
Yes Neg Neg Neg
8 4 1 Low 23 None None Asymptomatic Vaginal 2870 30 9-10-10 7.39 3 Yes Neg Neg Neg




Suspected IUGR Asymptomatic Vaginal 3100 20 9-10-10 7.31e7.36 2 Yes d d Neg
10 2 1 Average 26 Hypothyroidism Pyelonephritis Asymptomatic Vaginal 3800 70 9-10-10 7.29e7.32 2 Yes Neg Neg Neg
11 1 0 Low 26 None Placentamegaly Mild/Fever Vaginal 2910 15 9-9-9 7.16e7.31 2 Yes Neg Neg Neg
12 1 0 High 32 None None Asymptomatic CS 3630 50 4-8-9 7.29e7.33 4 No Neg Neg Neg
13 1 0 High 33 None None Asymptomatic Forceps 3030 5 9-10-10 7.31 3 Yes Neg Neg Neg
Abbreviations: N, patient number; G, gestation (in weeks); P, parity; COVID-19, coronavirus disease 2019; CS, caesarean section; NICU, neonatal intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
a Socio-economic status was defined as follows: low, the individual has insufficient financial resources and benefits from social services aids; normal, the individual is independent with sufficient income; high, the individual
has a higher education diploma (university).
b COVID-19 course was defined as critical when the woman needed admission to intensive care, as severe when the patient needed inpatient care, as asymptomatic when the woman presented with no symptoms at all
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general population. It is important to note that 38% of SARS-CoV-
2-positive mothers remained asymptomatic, which is much
lower than in the general adult population. In our centre, all
patients were tested upon admission. The rate of asymptomatic
individuals is therefore unlikely to be underestimated.
Eleven of 13 (84%) women had a vaginal delivery and two had
a caesarean section (one for acute respiratory distress syndrome
related to COVID-19 and one for failure to progress). Among
women who delivered vaginally, one underwent labour induc-
tion for placentamegaly (placenta thickness >6 cm on prenatal
ultrasound), which was possibly related to COVID-19. All other
women had a spontaneous labour or induction for indications
unrelated to COVID-19.
Regarding the neonates, rooming in (85%) and breastfeeding
(69%) were encouraged. The median age at discharge (3 days) and
the rate of hospitalization (15%) indicate an excellent neonatal
outcome. The maternal and neonatal outcomes described in our
series provide additional supportive evidence to limit caesarean
sections to obstetric indications in cases of stable maternal and
foetal condition.
In conclusion, we report no cases of vertical transmission and no
detection of the presence of SARS-CoV-2 in placental swabs. Recent
publications, however, indicate that larger series are needed to
confirm these assessments. In addition, current data are limited to
third-trimester infections. First-trimester and second-trimester
infections still need to be characterized [4].
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